Active Ingredient Prescribing


What is Active Ingredient Prescribing?

The Department of Health has changed legislation so that Pharmaceutical Benefits Scheme (PBS) and Repatriation PBS (RPBS) medicines must be prescribed using the active ingredient names, instead of the brand name of a medicine.

Why is this change happening?

The goal of this initiative is to help people understand what medicines they are taking and to reduce the risk of people accidentally taking multiple doses of the same medicine under different names. Other benefits include allowing pharmacists to easily dispense an alternative generic medicine if the patient’s usual brand is unavailable and a potential reduction in out of pocket costs to patients and the PBS via increase uptake of generic medicines.

Is Active Ingredient Prescribing mandatory?

Active Ingredient Prescribing will become mandatory from 1 February 2021.

Are there any exceptions?

Yes, exceptions to active ingredient prescribing include:

  • Handwritten prescriptions
  • Paper-based medication charts in residential aged care settings
  • Medicines with four or more active ingredients
  • Non-medicinal items which don’t have active ingredients (e.g. dressings, nutritional products)
  • A small number of items that have been specifically excluded from active ingredient prescribing.

Will this change my prescribing workflow?

There may be minor changes to the way you prescribe within your clinical information software (CIS), which will vary depending on the software you use. We recommend getting in contact with your software provider if you have any questions about this or see their websites below for more information. 

Resources and further information